| Caplin Point Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524742 |
NSE Symbol : CAPLIPOINT |
P/E(TTM) : 41.71 |
|
ISIN Demat : INE475E01026 |
Div & Yield% : 0.35 |
EPS(TTM) : 55.22 |
|
Book Value(₹) : 269.76 |
Market Cap(₹Cr) : 17,505.87 |
Face Value(₹) : 2.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 202.95 | 191.36 | 189.22 | 175.18 | 182.57 | 173.61 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 202.95 | 191.36 | 189.22 | 175.18 | 182.57 | 173.61 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 62.79 | 61.08 | 31.73 | 59.22 | 32.03 | 41.25 |
| Total Income | 265.74 | 252.44 | 220.95 | 234.40 | 214.60 | 214.86 |
| Total Expenditure | 108.54 | 107.77 | 97.50 | 99.33 | 95.96 | 98.57 |
| PBIDT | 157.20 | 144.67 | 123.45 | 135.07 | 118.64 | 116.29 |
| Interest | 0.05 | 0.05 | 0.07 | 0.05 | 0.04 | 0.04 |
| PBDT | 157.15 | 144.62 | 123.38 | 135.02 | 118.60 | 116.25 |
| Depreciation | 6.56 | 6.90 | 6.37 | 6.02 | 6.14 | 6.09 |
| Tax | 28.76 | 26.45 | 29.35 | 26.77 | 26.91 | 23.63 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 1.45 | 1.77 | 0.38 | -0.36 | -0.34 | 0.03 |
| Reported Profit After Tax | 120.38 | 109.50 | 87.28 | 102.59 | 85.89 | 86.50 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 120.38 | 109.50 | 87.28 | 102.59 | 85.89 | 86.50 |
| EPS (Unit Curr.) | 15.84 | 15.89 | 11.49 | 13.50 | 11.30 | 11.37 |
| EPS (Adj) (Unit Curr.) | 15.84 | 15.89 | 11.49 | 13.50 | 11.30 | 11.37 |
| Calculated EPS (Unit Curr.) | 15.84 | 14.41 | 11.48 | 13.50 | 11.30 | 11.38 |
| Calculated EPS (Adj) (Unit Curr.) | 15.84 | 14.41 | 11.48 | 13.50 | 11.30 | 11.38 |
| Calculated EPS (Ann.) (Unit Curr.) | 63.36 | 57.63 | 45.94 | 53.99 | 45.21 | 45.53 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 63.36 | 57.63 | 45.94 | 53.99 | 45.21 | 45.53 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 200.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 15.20 | 15.20 | 15.20 | 15.20 | 15.20 | 15.20 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 77.46 | 75.60 | 65.24 | 77.10 | 64.98 | 66.98 |
| PBDTM(%) | 77.43 | 75.57 | 65.20 | 77.08 | 64.96 | 66.96 |
| PATM(%) | 59.32 | 57.22 | 46.13 | 58.56 | 47.04 | 49.82 |
